Abstract. We have recently shown that discrete foci are present in the nuclei of mammalian cells in which each of the Ul, U2, U4/U6, and U5 snRNPs involved in pre-mRNA splicing, and the non-snRNP-splicing factor U2AF, are concentrated (Carmo-Fonseca, M., D. Tollervey, R. Pepperkok, S. Barabino, A . Merdes, Here, we identify these snRNP-rich organelles as coiled bodies. snRNPs no longer concentrate in coiled bodies after cells are treated with the transcription inhibitors a-amanitin or actinomycin D. snRNP association with coiled bodies is also disrupted by heat shock . This indicates that the association of T HE development of in vitro splicing extracts from mammalian and yeast systems has resulted in major advances in understanding the basic mechanism of pre-mRNA splicing (for reviews see references 9, 27, 38, 41, 54) . The splicing reaction involves two sequential transesterification reactions, similar to that seen with group II self-splicing introns (reviewed in reference 31) . Unlike selfsplicing introns however, nuclear pre-mRNA splicing requires a complex set of trans-acting splicing factors which bind to substrate RNAs in an ordered pathway to form an active splicing complex or "spliceosome" (8, 17, 22, 26, 32, and 47) . Major components ofspliceosomes are the Ul, U2, U4/ U6, and U5 snRNPs, all ofwhich are required for both spliceosome assembly and splicing. In addition to these snRNNs, recent studies have identified a number of non-snRNP protein factors which are also required for splicing in vitro (4,23,25,33,34,55,69,74,75) .In contrast with the substantial progress in dissecting the splicing machinery in vitro, comparatively little is known about how the splicing factors are organized in vivo, or how splicing is integrated in the nucleus with transcription or RNA processing reactions such as 3' polyadenylation . Many previous studies have shown by indirect immunofluorescence that autoimmune and monoclonal antibodies specific for